References

  1. Ghana Malaria Programme Review: final report. National Malaria Control Programme 2013. Acessed March 14, 2017.

  2. World Health Organization. World Malaria Report 2011. Accessed March 10, 2017.

  3. World Health Organization. Global Malaria Programme. Malaria: Global Fund proposal development 2011. Accessed Febrary 12, 2017

  4. Sohail M, Shakeel S, Kumari S et al. Prevalence of Malaria Infection and Risk Factors Associated with Anaemia among Pregnant Women in Semiurban Community of Hazaribag, Jharkhand, India. BioMed Research International. 2015; 2015: 740512. PubMed | Google Scholar

  5. Malaria in pregnancy. Training Manuel for Health Providers 2005. Accessed March 15, 2017

  6. De Beaudrap P, Turyakira E, White LJ et al. Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment. Malaria Journal. 2013; 12: 139. PubMed | Google Scholar

  7. Roll Back Malaria Partnership: Eliminating Malaria: learning from the past, looking ahead 2011. Accessed March 12, 2017

  8. Takem EN, D'Alessandro U. Malaria in pregnancy. Mediterranean Journal of Hematology and Infectious Diseases. 2013; 5(1): e2013010. PubMed | Google Scholar

  9. Ministry of Health. Anti-Malaria Drug Policy for Ghana 2014. Accessed March 1, 2017.

  10. Ghana Health Service. Ghana Health Service 2011. Annual Report. 2011. Google Scholar

  11. World Health Organization. Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine Pyrimethamine (IPTp SP). Updated WHO Policy Recommendation. October 2012. Google Scholar

  12. Orish VN, Onyeabor OS, Boampong JN et al. Prevalence of intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) use during pregnancy and other associated factors in Sekondi-Takoradi, Ghana. African Health Sciences. 2015; 15(4): 1087-1096. PubMed | Google Scholar

  13. RBM. RBM Partnership. The global malaria action plan, Geneva: WHO. 2008. Google Scholar

  14. Oyibo WA, Agomo CO. Scaling up of intermittent preventive treatment of malaria in pregnancy using sulphadoxine-pyrimethamine: prospects and challenges. Matern Child Health J. 2011; 15(4): 542-552. PubMed | Google Scholar

  15. d'Almeida TC, Agboton-Zoumenou MA, Garcia A, Massougbodji A, Briand V, Imorou Y, Cottrell G. Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation. Parasit Vectors. 2011; 4: 108. PubMed | Google Scholar

  16. Ghana Heath Service. Annual Report. Sunyani Municipality. 2013. Google Scholar

  17. Ghana Health Service. District Health Information Management System DHIMS II. Intermittent Preventive Treatment Uptake. 2015. Google Scholar

  18. Ghana Demographic and Health Survey. Ghana Demographic and Health Survey 2014. Accessed March 29, 2017.

  19. Antwi G. Factors influencing the uptake of intermittent preventive treatment of malaria in pregnancy in Bosomtwe district of Ghana. Kumasi, Ghana: Kwami Nkrumah University of Science and Technology. 2010. Google Scholar

  20. Hill J, Hoyt J, van Eijk AM et al. Factors Affecting the Delivery, Access and Use of Interventions to Prevent Malaria in Pregnancy in Sub-Saharan Africa: a systematic review and meta-analysis. Noor AM, ed PLoS Medicine. 2013; 10(7): e1001488. PubMed | Google Scholar

  21. Amoran OE, Ariba AA, Iyaniwura CA. Determinants of intermittent preventive treatment of malaria during pregnancy (IPTp) utilization in a rural town in Western Nigeria. Reproductive Health. 2012; 9: 12. PubMed | Google Scholar

  22. Takem EN, Achidi EA, Ndumbe PM. Use of intermittent preventive treatment for malaria by pregnant women in Buea, Cameroon. Acta Tropica. 2009; 112(1): 54-58. PubMed | Google Scholar

  23. Exavery A, Mbaruku G, Mbuyita S, Makemba A, Kinyonge IP, Kweka H. Factors affecting uptake of optimal doses of sulphadoxine-pyrimethamine for intermittentpreventive treatment of malaria in pregnancy in six districts of Tanzania. Malar J. 2014; 13: 22. PubMed | Google Scholar

  24. Nankwanga HA, Gorette N. Adherence to Intermittent Preventive Treatment for Malaria in Pregnancy. Afri J of Midwifery and Women's Health. 2008; 2: 131-40. Google Scholar

  25. Akaba GO, Otubu J, Agida ET, Onafowokan O. Knowledge and utilization of malaria preventive measures among pregnant women at a tertiary hospital in Nigeria's federal capital territory. Niger J Clin Pract. 2013; 16(2): 201-206. PubMed | Google Scholar

  26. Enato E FO, Okhamafe AO, Okpere EE. A survey of knowledge, attitude and practice of malaria management among pregnant women from two health care facilities in Nigeria. Acta Obstetricia et Gynecologica Scandinavica. 2007; 86(1): 33-6. Google Scholar

  27. Chepkemoi Ng'etich Mutulei A. Factors Influencing the Uptake of Intermittent Preventive Treatment for Malaria in Pregnancy: evidence from Bungoma East District, Kenya. American Journal of Public Health Research. 2013; 1(5): 110-123. Google Scholar

  28. Bouyou-Akotet MK, Mawili-Mboumba DP, Kombila M. Antenatal care visit attendance, intermittent preventive treatment and bed net use during pregnancy in Gabon. BMC Pregnancy and Childbirth. 2013; 13: 52. PubMed | Google Scholar

  29. Gies S, Coulibaly SO, Ky C, Ouattara FT, Brabin BJ et al. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso. Am J Trop Med Hyg. 2009; 80(3): 460-469. PubMed | Google Scholar

  30. Kibusi SM, Kimunai E, Hines CS. Predictors for uptake of intermittent preventive treatment of malaria in pregnancy (IPTp) in Tanzania. BMC Public Health. 2015; 15: 540. PubMed | Google Scholar